tenk.fyi

Aspire Biopharma Holdings, Inc.

ASBPNasdaq· Pharmaceutical Preparations

Price History

Revenue

-

Net Income

-$12.5M

380.9% YoY

EPS

-

Cash

-

FY 2024 · As of 2024-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro